echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > State Food and Drug Administration: From January 1, 2023, electronic declaration of drug registration applications will be implemented

    State Food and Drug Administration: From January 1, 2023, electronic declaration of drug registration applications will be implemented

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On November 30, the NMPA website published an announcement
    on the implementation of electronic declaration of drug registration applications.
    The full text is as follows:
     
    In order to improve the efficiency of drug review and approval, the State Food and Drug Administration has decided to implement electronic submission of application materials for drug registration, and the specific requirements are announced as follows:
     
    1.
    Starting from January 1, 2023, the application submitted by the applicant for review and approval of drug registration and supplementary information during the review process will be adjusted to submit the application materials in electronic form, and the applicant does not need to submit paper declaration materials
    .
    The existing working procedures remain unchanged
    .
     
    2.
    The applicant shall prepare the electronic declaration materials in accordance with the current regulations and the requirements of electronic declaration materials, and submit the CD-ROM to the Drug Evaluation Center of the State Food and Drug Administration (hereinafter referred to as the Drug Review Center) for application
    .
    The Drug Review Center will carry out acceptance, review and approval based on electronic declaration materials
    .
    The technical requirements related to electronic declaration materials shall be separately
    issued by the Drug Review Center.
     
    3.
    From the date of implementation of this announcement, the electronic documents for accepting administrative licenses for drug registration applications will be immediately pushed by the "Drug Business Application System" and "Drug eCTD Registration System", and the electronic documents for accepting administrative licenses have the same legal effect
    as paper documents.
     
    4.
    From the date of implementation of this announcement, if the applicant uses the electronic general technical file (eCTD) for the declaration, there is no need to submit paper declaration materials, and other requirements still need to be implemented
    in accordance with the "Announcement on the Implementation of the Application of Electronic General Technical Document for Drugs" (No.
    119 of 2021).
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.